Synthesis of fusidane triterpenoid Mannich bases as potential antibacterial and antitumor agents

被引:2
作者
Salimova, Elena V. [1 ]
Parfenova, Lyudmila V. [1 ]
Ishmetova, Diana V. [2 ]
Zainullina, Liana F. [2 ]
Vakhitova, Yulia V. [2 ]
机构
[1] Russian Acad Sci, Inst Petrochem & Catalysis, Ufa Fed Res Ctr, Ufa, Russia
[2] Russian Acad Sci, Inst Biochem & Genet, Ufa Fed Res Ctr, Ufa, Russia
基金
英国惠康基金;
关键词
Fusidane triterpenoids; Mannich bases; propargyl group; anticancer activity; antibacterial activity; fungicidal activity; ANTIMALARIAL ACTIVITY; BIOLOGICAL-ACTIVITY; MOLECULAR DOCKING; AMIDE DERIVATIVES; NATURAL-PRODUCTS; BINDING-SITE; ACID; DISCOVERY;
D O I
10.1080/14786419.2022.2163483
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Mannich bases (8 examples) were synthesized via aminomethylation of fusidane propargyl esters. In vitro antimicrobial screening against key ESKAPE pathogens showed that the fusidic acid based Mannich products exhibit a high antimicrobial effect against Gram-positive bacteria Staphylococcus aureus and the fungus Cryptococcus neoformans. Moreover, the cytotoxic effect of fusidic acid and its analogs, which showed high antibacterial activity, was determined by MTT assay on cancer HepG2, HCT-116, SH-SY5Y, MCF-7, A549 and conditionally normal cells HEK293. A remarkable cytotoxic activity of fusidic acid propargyl ester and its aminomethylene derivatives against cancer and nontumoral HEK293 cells with IC50 values within 4.2-25 mu M was found.
引用
收藏
页码:3956 / 3963
页数:8
相关论文
共 43 条
  • [1] Helping Chemists Discover New Antibiotics
    Blaskovich, Mark A. T.
    Zuegg, Johannes
    Elliott, Alysha G.
    Cooper, Matthew A.
    [J]. ACS INFECTIOUS DISEASES, 2015, 1 (07): : 285 - 287
  • [2] Blicke F.F., 2011, Organic Reactions, P303, DOI DOI 10.1002/0471264180.OR001.10
  • [3] Synthesis and Anticonvulsant Activity of New N-Mannich Bases Derived from 5-Cyclopropyl-5-phenyl-hydantoins
    Byrtus, Hanna
    Obniska, Jolanta
    Czopek, Anna
    Kaminski, Krzysztof
    [J]. ARCHIV DER PHARMAZIE, 2011, 344 (04) : 231 - 241
  • [4] Synthesis, antifungal activity and potential mechanism of fusidic acid derivatives possessing amino-terminal groups
    Cao, Yucheng
    Ni, Jingxuan
    Ji, Wentao
    Shang, Kangle
    Liang, Kaicheng
    Lu, Jing
    Bi, Yi
    Luo, Xiaomin
    [J]. FUTURE MEDICINAL CHEMISTRY, 2020, 12 (09) : 763 - 774
  • [5] Synthesis of Fusidic Acid Derivatives Yields a Potent Antibiotic with an Improved Resistance Profile
    Chavez, Martin Garcia
    Garcia, Alfredo
    Lee, Hyang Yeon
    Lau, Gee W.
    Parker, Erica N.
    Komnick, Kailey E.
    Hergenrother, Paul J.
    [J]. ACS INFECTIOUS DISEASES, 2021, 7 (02): : 493 - 505
  • [6] Synthesis of Antitumor-Active Betulinic Acid-Derived Hydroxypropargylamines by Copper-Catalyzend Mannich Reactions
    Csuk, Rene
    Nitsche, Christoph
    Sczepek, Ronny
    Schwarz, Stefan
    Siewert, Bianka
    [J]. ARCHIV DER PHARMAZIE, 2013, 346 (03) : 232 - 246
  • [7] 2-[4-(4-Methoxyphenylcarbonyloxy)benzylidene]-6-dimethylaminomethyl cyclohexanone hydrochloride: A Mannich base which inhibits the growth of some drug-resistant strains of Mycobacterium tuberculosis
    Das, S.
    Das, U.
    Bandy, B.
    Gorecki, D. K. J.
    Dimmock, J. R.
    [J]. PHARMAZIE, 2010, 65 (11): : 849 - 850
  • [8] Novel antimycobacterial C-21 amide derivatives of the antibiotic fusidic acid: synthesis, pharmacological evaluation and rationalization of media-dependent activity using molecular docking studies in the binding site of human serum albumin
    Dziwornu, Godwin Akpeko
    Kamunya, Stephanie
    Ntsabo, Tando
    Chibale, Kelly
    [J]. MEDCHEMCOMM, 2019, 10 (06) : 961 - 969
  • [9] Synthesis and biological characterisation of ester and amide derivatives of fusidic acid as antiplasmodial agents
    Espinoza-Moraga, Marlene
    Singh, Kawaljit
    Njoroge, Mathew
    Kaur, Gurminder
    Okombo, John
    De Kock, Carmen
    Smith, Peter J.
    Wittlin, Sergio
    Chibale, Kelly
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (03) : 658 - 661
  • [10] Gul HI, 2004, ARZNEIMITTEL-FORSCH, V54, P359